[THE USE IN PSYCHIATRIC PRACTICE OF A NEW NEUROLEPTIC DRUG OF THE BUTYROPHENONE SERIES: 20-28 M.D. (SEDALANDE)].
D014150:Antipsychotic Agents; D002090:Butyrophenones; D006801:Humans; D006993:Hypnotics and Sedatives; D001523:Mental Disorders
D014150:Antipsychotic Agents; D002090:Butyrophenones; D006993:Hypnotics and Sedatives
HYPNOTICS AND SEDATIVES; MENTAL DISORDERS